101 related articles for article (PubMed ID: 24702227)
1. Increased expression of Dec-205, Bcl-10, Tim-3, and Trem-1 mRNA in chronic otitis media with cholesteatoma.
Kim MG; Park DC; Oh IH; Kim YI; Choi SA; Jung SY; Kang HM; Yeo SG
Acta Otolaryngol; 2014 May; 134(5):475-80. PubMed ID: 24702227
[TBL] [Abstract][Full Text] [Related]
2. Expression of C-type lectin receptor mRNA in chronic otitis media with cholesteatoma.
Kim SH; Han SH; Byun JY; Park MS; Kim YI; Yeo SG
Acta Otolaryngol; 2017 Jun; 137(6):581-587. PubMed ID: 28440726
[TBL] [Abstract][Full Text] [Related]
3. Expression of C-type lectin receptor mRNA in otitis media with effusion and chronic otitis media with and without cholesteatoma.
Doo JG; Kim YI; Shim HS; Kim DJ; Park JW; Dong SH; Kim SH; Yeo SG
Auris Nasus Larynx; 2019 Oct; 46(5):672-680. PubMed ID: 30609964
[TBL] [Abstract][Full Text] [Related]
4. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
[TBL] [Abstract][Full Text] [Related]
5. Expression of toll-like receptors in chronic otitis media and cholesteatoma.
Hirai H; Kariya S; Okano M; Fukushima K; Kataoka Y; Maeda Y; Nishizaki K
Int J Pediatr Otorhinolaryngol; 2013 May; 77(5):674-6. PubMed ID: 23380629
[TBL] [Abstract][Full Text] [Related]
6. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
Yetiser S; Satar B; Aydin N
Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in Toll-like receptors 2 and 4 genes and their expression in chronic suppurative otitis media.
Jotic A; Jesic S; Zivkovic M; Tomanovic N; Kuveljic J; Stankovic A
Auris Nasus Larynx; 2015 Dec; 42(6):431-7. PubMed ID: 26055429
[TBL] [Abstract][Full Text] [Related]
8. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
Sanković-Babić S; Sofronić-Milosavljević Lj
Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
[TBL] [Abstract][Full Text] [Related]
9. C-type lectin receptors mRNA expression in patients with otitis media with effusion.
Lee JH; Park DC; Oh IW; Kim YI; Kim JB; Yeo SG
Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1846-51. PubMed ID: 24094722
[TBL] [Abstract][Full Text] [Related]
10. [Differential expression of toll-like receptors in chronic suppurative otitis media and cholesteatoma].
Si Y; Zhang ZG; Huang CY; He JF; Feng LQ; Chen YB; Chen T; Huang X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 May; 47(5):388-93. PubMed ID: 22883581
[TBL] [Abstract][Full Text] [Related]
11. TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation.
Jiang H; Si Y; Li Z; Huang X; Chen S; Zheng Y; Xu G; Chen X; Chen Y; Liu Y; Xiong H; Huang Q; Liang M; Zhang Z
Sci Rep; 2016 Dec; 6():38761. PubMed ID: 27934908
[TBL] [Abstract][Full Text] [Related]
12. Is there a relationship between myeloperoxidase activity and conductive hearing loss in chronic otitis media complicated by cholesteatoma?
Celebi Erdivanli O; Sanli A
Ear Nose Throat J; 2015; 94(4-5):166-92. PubMed ID: 25923274
[TBL] [Abstract][Full Text] [Related]
13. Neurotologic treatment of acquired cholesteatoma.
Burggraaff B; Luxford WM; Doyle KJ
Am J Otol; 1995 Jul; 16(4):480-5. PubMed ID: 8588649
[TBL] [Abstract][Full Text] [Related]
14. Expression of endoplasmic reticulum stress mRNAs in otitis media.
Jung SY; Kwon KJ; Min HK; Kang DW; Park DC; Kim YI; Ryu J; Yeo SG
Acta Otolaryngol; 2021 May; 141(5):459-465. PubMed ID: 33641571
[TBL] [Abstract][Full Text] [Related]
15. Management of chronic otitis media in the only hearing ear.
Battaglia AS; Sabri AN; Jackson CG
Laryngoscope; 2002 Apr; 112(4):681-5. PubMed ID: 12150523
[TBL] [Abstract][Full Text] [Related]
16. Quantitative measurement of m-RNA levels to assess expression of cyclooxygenase-II, inducible nitric oxide synthase and 12-lipoxygenase genes in middle ear cholesteatoma.
Çatlı T; Bayazıt Y; Yılmaz A; Menevşe A; Gökdoğan O; Göksu N; Özbilen S
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1471-5. PubMed ID: 23832258
[TBL] [Abstract][Full Text] [Related]
17. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
[TBL] [Abstract][Full Text] [Related]
18. Expression of aquaporins mRNAs in patients with otitis media.
Jung SY; Kim SS; Kim YI; Kim HS; Kim SH; Yeo SG
Acta Otolaryngol; 2018 Aug; 138(8):701-707. PubMed ID: 29607712
[TBL] [Abstract][Full Text] [Related]
19. Expression of tumor necrosis factor-α, interleukin-1α, interleukin-6 and interleukin-10 in chronic otitis media with bone osteolysis.
Kuczkowski J; Sakowicz-Burkiewicz M; Iżycka-Świeszewska E; Mikaszewski B; Pawełczyk T
ORL J Otorhinolaryngol Relat Spec; 2011; 73(2):93-9. PubMed ID: 21311206
[TBL] [Abstract][Full Text] [Related]
20. Expression of pattern recognition receptors in cholesteatoma.
Lee HY; Park MS; Byun JY; Kim YI; Yeo SG
Eur Arch Otorhinolaryngol; 2014 Feb; 271(2):245-53. PubMed ID: 23440434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
